Skip to main content
Premium Trial:

Request an Annual Quote

Allen McClay, Tony Galindo, Stratagene, Illumina

Premium

People in the News

Allen McClay, chairman and founder of Almac Sciences, was knighted for his services to both business and charity, Almac Diagnostics said last week.

McClay founded Galen Ltd, which became Galen Holdings Plc. When he retired from Galen Holdings in 2001, he invested approximately £240 million ($423 million) to establish Almac Sciences.

McClay has donated almost £20 million through the McClay Trust for research at Queen's University Belfast.


Tony Galindo joined SciGene as director of product manufacturing, SciGene said last week.

Galindo comes to SciGene after nearly 20 years at Agilent, formerly Hewlett-Packard, where he held various senior manufacturing management positions within the Life Sciences and Chemical Analysis Group.

 

New Product Watch

Stratagene said last week that its ArrayAssist Exon and ArrayAssist Expression software is now available for Mac OS X 10.4.

Stratagene said that the new ArrayAssist line of software products enables scientists to analyze Affymetrix GeneChip Exon Arrays as well as data from other microarray platforms.

Both packages are fully integrated with Stratagene's PathwayArchitect pathway analysis software, the company said. In addition to Mac OS X, the ArrayAssist Expression and ArrayAssist Exon software are both compatible with Windows and Linux.


Illumina has begun shipping its Sentrix HumanHap300 Genotyping BeadChips for genome-wide disease association studies.

The platform uses Illumina's Infinium assay method to analyze over 317,000 high-value SNP loci per sample, according to the company. Content is mostly derived from tagSNPs identified and validated in the International HapMap Project, Illumina said.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.